Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07262554
PHASE2

N-acetylcysteine for Root Canal Treatment of Necrotic Teeth With Apical Periodontitis

Sponsor: Alexandria University

View on ClinicalTrials.gov

Summary

A randomized controlled trial comparing the postoperative pain intensity, periapical biomarkers level, and periapical healing in patients with necrotic mature teeth and apical periodontitis treated with N-acetylcysteine (NAC), as an intracanal and adjunctive systemic medication, versus calcium hydroxide (Ca(OH)₂) intracanal medication alone.

Official title: Evaluation of N-acetylcysteine as an Intracanal and Adjunctive Systemic Medication in Root Canal Treatment of Necrotic Mature Teeth With Apical Periodontitis: a Randomized Controlled Clinical Trial

Key Details

Gender

All

Age Range

16 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2025-11-15

Completion Date

2026-06

Last Updated

2025-12-30

Healthy Volunteers

No

Interventions

DRUG

Calcium hydroxide (Ca(OH)₂)

UltraCal XS calcium hydroxide (Ca(OH)₂) intracanal medication for 7 days

DRUG

N-Acetylcysteine (NAC)

N-acetylcysteine (NAC) intracanal medication for 7 days and 600 mg/day oral NAC for 21 days

Locations (1)

Faculty of Dentistry, Alexandria University

Alexandria, Egypt